3 year experience of deferasirox in a small paediatric cohort of beta thalassaemia major patients

被引：0
|
作者：
Welch, J. C. [1 ]
机构：
[1] Sheffield Childrens NHS Fdn Trust, Dept Haematol, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 153卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
157
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] DEFERASIROX IN PAEDIATRIC PATIENTS WITH THALASSAEMIA MAJOR: 1-YEAR RESULTS FROM A LARGE PAEDIATRIC COHORT ENROLLED IN THE PROSPECTIVE, IMULTICENTRE EPIC STUDY
    Filosa, A.
    Elalfy, M.
    Li, C.
    Lai, Y.
    Chan, L. L.
    Sutcharitchan, P.
    Habr, D.
    Domokos, G.
    Roubert, B.
    El-Beshlawy, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 78 - 79
  • [2] Successful desensitization to deferasirox in a paediatric patient with β-Thalassaemia major
    Davies, Grace Isobel
    Davies, Domenica
    Charles, Sarah
    Barnes, Sara Laura
    Bowden, Donald
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2017, 28 (02) : 199 - 201
  • [3] Effects of dual chelation therapy with deferasirox and deferoxamine in patients with beta thalassaemia major
    Zargari, Ahmad
    Wu, Simon
    Greenway, Anthea
    Cheng, Ken
    Kaplan, Zane
    VOX SANGUINIS, 2022, 117 (05) : 733 - 737
  • [4] Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre
    Sousos, Nikolaos
    Sinakos, Emmanouil
    Klonizakis, Philippos
    Adamidou, Despoina
    Daniilidis, Angelos
    Gigi, Eleni
    Vetsiou, Evaggelia
    Tsioni, Konstantina
    Mandala, Eudokia
    Vlachaki, Efthymia
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 140 - 142
  • [5] Deferasirox pharmacokinetic evaluation in b-thalassaemia paediatric patients
    Allegra, Sarah
    Cusato, Jessica
    De Francia, Silvia
    Pirro, Elisa
    Massano, Davide
    Piga, Antonio
    D'Avolio, Antonio
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (05) : 525 - 528
  • [6] Effect of deferasirox (ICL670) on arterial function in patients with beta-thalassaemia major
    Cheung, Y. F.
    Chan, Godfrey C. F.
    Ha, S. Y.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (05) : 728 - 733
  • [7] Effect of nutrition support on immunity in paediatric patients with beta-thalassaemia major
    Tienboon, P
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2003, 12 (01) : 61 - 65
  • [8] Deferasirox reduces cardiac iron in beta-thalassaemia patients
    Pennell, Dudley
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (02) : 70 - 70
  • [9] Post-transplant chelating therapy with deferasirox in patients with beta thalassaemia
    Yesilipek, M. A.
    Karasu, G.
    Akcan, M.
    Uygun, V.
    Bolat, Z.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S197 - S198
  • [10] A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload
    Wei, Zhenbin
    Yang, Gaohui
    Huang, Yumei
    Peng, Peng
    Long, Liling
    Long, Yuan
    Huang, Xiaoping
    Zhou, Xuemei
    Lai, Yongrong
    Liu, Rongrong
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (03) : E81 - E83
12345